A number of interesting reports and reviews on autologous bone marrow transplantation (ABMT) in patients with acute leukaemias (AL), malignant lymphomas (ML) and solid tumours has been published in the last few years. Similarly to allogeneic BMT, while the initial trials were in practice, feasibility studies in malignancies, whether refractory or relapsed after first or second line conventional chemotherapy, ABMT has been subsequently utilized in patients in complete remission, with minimal residual disease. In this review we shall discuss the most important clinical studies performed with ABMT in ANLL, ALL, chronic granulocytic leukaemia (CGL) and ML. The results in solid tumours have been, in general, rather discouraging, with some exceptions, notable metastatizing neuroblastoma.
|Number of pages||12|
|Publication status||Published - 1986|
ASJC Scopus subject areas